BlackRock’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $752M | Buy |
39,098,389
+704,770
| +2% | +$13.9M | 0.01% | 841 |
|
|
2025
Q4 | $727M | Buy |
38,393,619
+1,291,591
| +3% | +$23.9M | 0.01% | 854 |
|
|
2025
Q3 | $692M | Buy |
37,102,028
+690,324
| +2% | +$12.9M | 0.01% | 876 |
|
|
2025
Q2 | $671M | Sell |
36,411,704
-2,448,797
| -6% | -$43.5M | 0.01% | 853 |
|
|
2025
Q1 | $679M | Buy |
38,860,501
+1,840,162
| +5% | +$31M | 0.01% | 834 |
|
|
2024
Q4 | $641M | Buy |
37,020,339
+1,423,019
| +4% | +$26M | 0.01% | 918 |
|
|
2024
Q3 | $662M | Buy |
35,597,320
+1,210,446
| +4% | +$20.4M | 0.01% | 875 |
|
|
2024
Q2 | $530M | Buy |
34,386,874
+188,609
| +0.6% | +$2.7M | 0.01% | 965 |
|
|
2024
Q1 | $505M | Sell |
34,198,265
-269,944
| -0.8% | -$3.74M | 0.01% | 1029 |
|
|
2023
Q4 | $492M | Buy |
34,468,209
+1,139,125
| +3% | +$16.2M | 0.01% | 1026 |
|
|
2023
Q3 | $465M | Buy |
33,329,084
+180,359
| +0.5% | +$2.31M | 0.01% | 948 |
|
|
2023
Q2 | $390M | Buy |
33,148,725
+486,114
| +1% | +$5.53M | 0.01% | 1111 |
|
|
2023
Q1 | $376M | Sell |
32,662,611
-69,582
| -0.2% | -$861K | 0.01% | 1111 |
|
|
2022
Q4 | $407M | Buy |
32,732,193
+655,198
| +2% | +$8.35M | 0.01% | 1024 |
|
|
2022
Q3 | $421M | Sell |
32,076,995
-398,115
| -1% | -$5.88M | 0.01% | 918 |
|
|
2022
Q2 | $454M | Buy |
32,475,110
+11,626
| +0% | +$155K | 0.01% | 920 |
|
|
2022
Q1 | $483M | Sell |
32,463,484
-741,115
| -2% | -$10.1M | 0.01% | 1011 |
|
|
2021
Q4 | $450M | Buy |
33,204,599
+2,066,288
| +7% | +$29.2M | 0.01% | 1107 |
|
|
2021
Q3 | $458M | Buy |
31,138,311
+59,098
| +0.2% | +$998K | 0.01% | 1050 |
|
|
2021
Q2 | $566M | Buy |
31,079,213
+637,071
| +2% | +$11.3M | 0.02% | 930 |
|
|
2021
Q1 | $528M | Buy |
30,442,142
+1,292,607
| +4% | +$22.7M | 0.02% | 954 |
|
|
2020
Q4 | $506M | Buy |
29,149,535
+919,957
| +3% | +$14.7M | 0.02% | 885 |
|
|
2020
Q3 | $389M | Sell |
28,229,578
-452,937
| -2% | -$6.65M | 0.01% | 895 |
|
|
2020
Q2 | $414M | Sell |
28,682,515
-458,418
| -2% | -$6.03M | 0.02% | 837 |
|
|
2020
Q1 | $318M | Buy |
29,140,933
+1,419,838
| +5% | +$26.2M | 0.02% | 863 |
|
|
2019
Q4 | $592M | Buy |
27,721,095
+1,101,341
| +4% | +$24.7M | 0.02% | 699 |
|
|
2019
Q3 | $611M | Buy |
26,619,754
+1,341,510
| +5% | +$28.6M | 0.03% | 629 |
|
|
2019
Q2 | $498M | Sell |
25,278,244
-251,661
| -1% | -$4.9M | 0.02% | 744 |
|
|
2019
Q1 | $497M | Buy |
25,529,905
+63,064
| +0.2% | +$1.2M | 0.02% | 737 |
|
|
2018
Q4 | $420M | Sell |
25,466,841
-108,007
| -0.4% | -$2.17M | 0.02% | 748 |
|
|
2018
Q3 | $591M | Buy |
25,574,848
+34,048
| +0.1% | +$771K | 0.03% | 663 |
|
|
2018
Q2 | $555M | Sell |
25,540,800
-606,028
| -2% | -$11.8M | 0.03% | 665 |
|
|
2018
Q1 | $461M | Buy |
26,146,828
+577,060
| +2% | +$10.2M | 0.02% | 749 |
|
|
2017
Q4 | $480M | Buy |
25,569,768
+1,673,758
| +7% | +$33.3M | 0.02% | 728 |
|
|
2017
Q3 | $524M | Buy |
23,896,010
+14,325,578
| +150% | +$324M | 0.03% | 635 |
|
|
2017
Q2 | $231M | Buy |
9,570,432
+277,421
| +3% | +$7.05M | 0.01% | 1177 |
|
|
2017
Q1 | $260M | Buy |
9,293,011
+9,193,585
| +9,247% | +$241M | 0.01% | 1075 |
|
|
2016
Q4 | $2.43M | Buy |
99,426
+12,711
| +15% | +$291K | ﹤0.01% | 1157 |
|
|
2016
Q3 | $2.18M | Buy |
86,715
+5,327
| +7% | +$128K | ﹤0.01% | 1173 |
|
|
2016
Q2 | $1.68M | Buy |
81,388
+18,548
| +30% | +$387K | ﹤0.01% | 1235 |
|
|
2016
Q1 | $1.26M | Buy |
62,840
+5,433
| +9% | +$104K | ﹤0.01% | 1276 |
|
|
2015
Q4 | $1.16M | Sell |
57,407
-197
| -0.3% | -$4.15K | ﹤0.01% | 1261 |
|
|
2015
Q3 | $1.33M | Buy |
57,604
+5,065
| +10% | +$129K | ﹤0.01% | 1185 |
|
|
2015
Q2 | $1.35M | Sell |
52,539
-4,940
| -9% | -$140K | ﹤0.01% | 1244 |
|
|
2015
Q1 | $1.91M | Buy |
57,479
+9,261
| +19% | +$301K | ﹤0.01% | 1102 |
|
|
2014
Q4 | $1.46M | Buy |
48,218
+5,634
| +13% | +$155K | ﹤0.01% | 1124 |
|
|
2014
Q3 | $1.04M | Buy |
42,584
+2,753
| +7% | +$76.3K | ﹤0.01% | 1203 |
|
|
2014
Q2 | $1.14M | Buy |
39,831
+9,991
| +33% | +$290K | ﹤0.01% | 1166 |
|
|
2014
Q1 | $832K | Buy |
29,840
+1,319
| +5% | +$36.2K | ﹤0.01% | 1244 |
|
|
2013
Q4 | $745K | Buy |
28,521
+4,910
| +21% | +$127K | ﹤0.01% | 1245 |
|
|
2013
Q3 | $543K | Buy |
23,611
+2,706
| +13% | +$66.7K | ﹤0.01% | 1235 |
|
|
2013
Q2 | $545K | Buy |
+20,905
| New | +$603K | ﹤0.01% | 1202 |
|
Other funds holding SBRA
VPM
VCM
N
CIM
BlackRock's SBRA Position: Q1 2026 in Review
BlackRock increased its Sabra Healthcare REIT (SBRA) stake by 1.8% in Q1 2026, buying an estimated $13.9M and bringing the position to 39,098,389 shares worth $752M. The position accounts for 0.01% of the portfolio, ranked #841.
BlackRock first reported a position in SBRA in Q2 2013 and has held it in 52 quarters since. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.
- BlackRock held 39,098,389 shares of Sabra Healthcare REIT worth $752M as of Q1 2026.
- BlackRock bought 704,770 Sabra Healthcare REIT shares in Q1 2026, an estimated $13.9M.
- Sabra Healthcare REIT made up 0.01% of BlackRock's portfolio in Q1 2026, its #841 holding.
- BlackRock first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 52 quarters since.
- 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.